Competition in asthma

Competition in asthma

Researchers are chipping away at genes for multigenic diseases, but it will be some time before the clinical and diagnostic utility of single genes in such diseases is known.

Sequana Therapeutics Inc. last week announced the cloning of a gene thought to be responsible for causing asthma in some patients.

Read the full 529 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers